America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Which Investors Should Avoid Robo Advisors outlines situations where automated options may underperform. This intro highlights alternatives to consider.
28,175 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Chipmakers retreat after Samsung delivers mixed earnings, triggering a broader sector reset. Intel and Applied Materi...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
A Trump-themed memecoin crash leaves close to a million holders deep in losses, even as the president discloses hefty...
IonQ is set to release Q1 2026 results after the bell, with investors weighing growth across five acquisitions, a Sky...
Apple has delivered outsized gains since Tim Cook took the helm. A $10,000 stake from that era would sit on a hefty b...
Wells Fargo analysts warn the AI investment surge resembles a euphoric bubble, advising investors to ride gains while...
NIO delivered a surprising Q4 2025 GAAP profit and outlined a 2026 path to positive non-GAAP earnings, supported by m...
SpaceX is rumored to target a June 12 IPO, igniting widespread speculation about a valuation that could dwarf most te...
SpaceX is weighing a high-profile IPO that could bring California a much-needed economic boost despite the chatter ar...
In a late-day turn, Bill Gates pulled out of India’s AI Impact Summit hours before his keynote, amplifying concerns o...
On June 3, 2026, stocks take breather wednesday as a rapid rally cools, with the S&P 500 slipping and investors weigh...